Clinical Trials Directory

Trials / Sponsors / MAXVAX Biotechnology Limited Liability Company

MAXVAX Biotechnology Limited Liability Company

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingSafety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in He
Respiratory Syncytial Virus (RSV)
Phase 12026-04-01
Active Not RecruitingA Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
Herpes Zoster
Phase 32025-12-15
RecruitingPhase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Respiratory Syncytial Virus (RSV)
Phase 32025-10-22
Not Yet RecruitingPhase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
Herpes Zoster
Phase 32024-12-09
Active Not RecruitingSafety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
Respiratory Syncytial Virus (RSV)
Phase 1 / Phase 22024-11-13
Active Not RecruitingEfficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and
Herpes Zoster
Phase 32024-07-13
Active Not RecruitingImmunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years a
Herpes Zoster
Phase 22023-05-07
Active Not RecruitingSafety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Todd
Rotavirus Infections, Rotavirus Gastroenteritis
Phase 22023-01-08
Active Not RecruitingSafety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years a
Herpes Zoster
Phase 12022-12-07